Yawen Wu

Yawen Wu is currently the Investor Director, China Resources at Genesis Care. Prior to this, they were a Senior Data Analyst at DaVita Inc. from April 2019 to November 2021. In this role, they provided analytics consulting and training to cross-functional business partners on topics like COVID budget financial modeling and revenue loss scenario analysis. Yawen also led the design and automation of business intelligence reports/interactive dashboards to support leadership decision making.

From September 2018 to February 2019, Yawen Wu was an Insight Analyst at RTE. In this role, they were responsible for leading projects to build instant insight/red flag notification leveraging new data sources through the use of technology.

Before that, they were a Senior Auditor at Deloitte Touche Tohmatsu LLC from October 2014 to December 2016. In this role, they were responsible for leading the transformation from traditional testing measurements to incorporate broader population insights allowing for improved oversight and decision making.

Yawen Wu started their career as a Financial Analyst Intern at Amazon from May 2013 to March 2014.

Yawen Wu attended Zhongnan University of Economics and Law, where they received their bachelor's degree in accounting. Yawen then pursued a master's degree in data analytics at Columbia University in the City of New York. In addition, Yawen Wu is certified by the Chinese Institute of Certified Public Accountants (CICPA).

Yawen Wu reports to Dan Collins, Founder & CEO. They work with Michael Guiney - Oncologist Director, GenesisCare, Kerry Zhang - Investor Director, China Resources, and Tim Tianwei Zhang - Investor Director, China Resources.